Page last updated: 2024-09-04

jolkinolide a and Bone Loss, Osteoclastic

jolkinolide a has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, XO; Liu, N; Peng, Q; Sun, WC; Wang, HB; Wang, Y; Wu, D; Xu, X	1

Other Studies

1 other study(ies) available for jolkinolide a and Bone Loss, Osteoclastic

Article	Year
17-Hydroxy-jolkinolide A inhibits osteoclast differentiation through suppressing the activation of NF-κB and MAPKs. International immunopharmacology, 2015, Volume: 29, Issue:2 Topics: Animals; Bone Resorption; Cell Differentiation; Cell Survival; Diterpenes; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; RANK Ligand	2015

Article

Year

17-Hydroxy-jolkinolide A inhibits osteoclast differentiation through suppressing the activation of NF-κB and MAPKs.

International immunopharmacology, 2015, Volume: 29, Issue:2

Topics: Animals; Bone Resorption; Cell Differentiation; Cell Survival; Diterpenes; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; RANK Ligand

2015